NCT06675240RecruitingPhase 1
Meditative Neurofeedback for Depression
Source: ClinicalTrials.gov · Last updated 9 Oct 2026
Brief summary (registry, in English)
The goal of this study is to test a meditative neurofeedback intervention for depressed mood.
- Status (registry)
- Recruiting
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- First submitted
- 3 Nov 2024
- Start date
- 15 Nov 2024
- Primary completion date
- 15 Nov 2027
- Lead sponsor
- University of California, San Diego
- Diseases
- Depression
- NCT number
- NCT06675240
What you commit to
- Study type: Interventional · Phase 1
- Planned participants: 60
- From 15 Nov 2024 to the primary completion date, 15 Nov 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- psychotic disorders
- bipolar disorder
Other
- active substance abuse/dependence
- displaying acutely suicidal behaviors
Who the study is looking for
- moderate depression per PHQ9 symptom ratings
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of California San Diego Coordinator of this site? Confirm its status | La Jolla | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.